The sensitivities of fifteen disease-associated strains of
M. intracellulare were tested
in vitro using Dubos Tween Albumin liquid medium to ten aminoglycoside and three peptide antibiotics. The drugs tested were SM, KM, DKB (Dideoxykanamycin B), AKM (Aminodeoxykanamycin), AMK (Amikacin), AMD (paromomycin), GM (Gentamicin), VSM (Ribostamycin), LVM (Lividomycin), TOB (Tobramycin), EVM (Enviomycin), CPRM (Capreomycin) and VM.
The strains isolated from the patients in our Institute, seven of the fifteen strains tested, showed low sensitivities against all drugs tested. The growth of only one strain each was inhibited by TOB, GM, VSM and AMK at the concentrations less than 1.56μg/m
l. The results obtained here were not encouraging for clinical trial.
The remaining eight strains tested, which were TMC (Trudeau Mycobacterial Culture Collection) strains, which were kindly provided by the U. S.-Japan Cooperative Medical Science Program-NIAID in 1975, showed considerable sensitivities to all aminoglycoside antibiotics tested, though the sensitivities to peptide antibiotics were not impressive.
The pattern of the sensitivities to these antibiotics was similar in the U. S. strains and in Japanese strains, except SM exhibited more potent activities against U. S. strains than Japanese strains. TOB and GM showed the most potent activity to
M. intracellulare among the drugs tested, and the least activities were exhibited by VM, CPRM and EVM, which were all peptide antibiotics. The remaining aminoglycosides were in between the two groups of the drugs in their activities against M. intracellulare.
The overall differences of sensitivity between U. S. strains and Japanese strains were not readily explanatory.
抄録全体を表示